Clinical Outcomes of COVID-19 and Impact on Disease Course in Patients with Inflammatory Bowel Disease

CONCLUSION: The prevalence of COVID-19 infection among patients with IBD was lower than that in the general population in Canada. Severe COVID-19, mortality, and flare of IBD were relatively rare, while a large proportion of patients received COVID-19 vaccination. Older age, comorbidities, active IBD disease, and systemic corticosteroid, but not immunosuppressive or biological therapy, were associated with severe COVID-19 infection.PMID:34858891 | PMC:PMC8632463 | DOI:10.1155/2021/7591141

Source: Canadian Journal of Gastroenterology - December 3, 2021 Category: Gastroenterology Authors: Panu Wetwittayakhlang Farah Albader Petra A Golovics Gustavo Dr ügg Hahn Talat Bessissow Alain Bitton Waqqas Afif Gary Wild Peter L Lakatos Source Type: research